Hiv

HIV treatment medications, often called antiretroviral drugs, are prescribed to manage human immunodeficiency virus (HIV) infection. Their overall aim is to limit viral replication and help preserve immune system function over the long term. These medicines are used as part of ongoing medical care and are typically selected based on the virus’s characteristics, the person’s health status, and other medications the person may be taking.

Common use cases for these medicines include long-term suppression of HIV viral load, management of acute or recent infection in clinical settings, and treatment adjustments when resistance or side effects arise. Some drugs that appear in HIV-focused collections also have roles in treating other viral infections; for example, certain formulations approved for hepatitis B virus are chemically similar to HIV drugs and may be listed alongside antiretrovirals for clinical reasons.

Different classes of antiretroviral medications are represented here, each working at a specific step of the virus lifecycle. Nucleoside reverse transcriptase inhibitors (NRTIs) interfere with the enzyme HIV uses to copy its genetic material. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) bind to the same enzyme in a different way. Protease inhibitors prevent the virus from maturing into infectious particles, and there are other classes such as integrase inhibitors and entry inhibitors. Examples of well-known medicines associated with these categories include epivir (lamivudine), epivir hbv (a formulation of lamivudine used for hepatitis B), kaletra (lopinavir/ritonavir, a protease inhibitor combination), and sustiva (efavirenz, an NNRTI).

Treatment strategies commonly use combinations of drugs from different classes to achieve stronger suppression of the virus and to reduce the chance that resistance will develop. Fixed-dose combinations and once-daily options are often sought for convenience, while some regimens are tailored to address co-existing conditions or to avoid interactions with other therapies. The choice of specific agents is guided by clinical judgement and testing that identifies viral resistance patterns and other medical considerations.

General safety considerations cover potential side effects, interactions with other medicines and supplements, and the need for periodic monitoring. Adverse effects vary by drug class and individual agent, ranging from mild symptoms to more serious laboratory abnormalities in rare cases. Many antiretrovirals are processed by liver enzymes and may affect or be affected by other compounds, so awareness of concomitant medications and supplements is important. Healthcare settings typically monitor blood tests and clinical status to assess tolerability and effectiveness.

When people compare options within this group, common factors include how well a medicine suppresses viral load, the likelihood and type of side effects, dosing frequency, pill burden, potential interactions, and specific approvals for co-infections or special populations. Formulation preferences, such as tablets versus liquids, and considerations around resistance history or previous treatment experience also influence selection. Information about individual medicines, their typical uses, and their safety profiles can help consumers understand why certain drugs may be offered as part of an HIV care plan.